ICON plc
(NASDAQ : ICLR)

( )
ICLR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MYOKMyoKardia, Inc. -0.02%222.401.8%$502.40m
HZNPHorizon Therapeutics Plc -0.05%74.275.8%$155.39m
VRXValeant Pharmaceuticals International, Inc. 3.29%17.5814.1%$103.44m
CTLTCatalent, Inc. -0.79%92.422.1%$84.83m
JAZZJazz Pharmaceuticals Plc -2.04%145.392.4%$82.09m
BHCBausch Health Cos., Inc. 3.29%17.580.0%$68.73m
ICLRICON plc -0.54%202.234.3%$48.88m
UTHRUnited Therapeutics Corp. -0.27%118.8514.1%$44.28m
ZGNXZogenix, Inc. 1.54%20.507.5%$42.04m
SAGESAGE Therapeutics, Inc. -4.03%67.258.6%$41.83m
ARGXargenx SE -2.19%256.800.0%$38.95m
ENDPEndo International Plc -5.69%5.478.7%$36.31m
AMRNAmarin Corp. Plc -3.28%4.721.5%$35.22m
PRGOPerrigo Co. Plc -2.82%44.866.8%$32.47m
GWPHGW Pharmaceuticals Plc 0.56%96.896.2%$29.96m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.